Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma

Conventional treatment or autologous transplantation has not been able to achieve long-term remission in patients with multiple myeloma (MM). Nonmyeloablative allogeneic transplantation might offer an option for cure without the high mortality associated with conventional conditioning. Here we prese...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gerull, Sabine (VerfasserIn) , Görner, Martin (VerfasserIn) , Benner, Axel (VerfasserIn) , Hegenbart, Ute (VerfasserIn) , Klein, Ulrike (VerfasserIn) , Schäfer, Hansjörg (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Ho, Anthony Dick (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 26 September 2005
In: Bone marrow transplantation
Year: 2005, Jahrgang: 36, Heft: 11, Pages: 963-969
ISSN:1476-5365
DOI:10.1038/sj.bmt.1705161
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/sj.bmt.1705161
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/1705161
Volltext
Verfasserangaben:S. Gerull, M. Goerner, A. Benner, U. Hegenbart, U. Klein, H. Schaefer, H. Goldschmidt and A.D. Ho

MARC

LEADER 00000caa a2200000 c 4500
001 1789625769
003 DE-627
005 20230426075810.0
007 cr uuu---uuuuu
008 220215s2005 xx |||||o 00| ||eng c
024 7 |a 10.1038/sj.bmt.1705161  |2 doi 
035 |a (DE-627)1789625769 
035 |a (DE-599)KXP1789625769 
035 |a (OCoLC)1341441599 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Gerull, Sabine  |e VerfasserIn  |0 (DE-588)1251853625  |0 (DE-627)1789626781  |4 aut 
245 1 0 |a Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma  |c S. Gerull, M. Goerner, A. Benner, U. Hegenbart, U. Klein, H. Schaefer, H. Goldschmidt and A.D. Ho 
264 1 |c 26 September 2005 
300 |b Diagramme 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.02.2022 
520 |a Conventional treatment or autologous transplantation has not been able to achieve long-term remission in patients with multiple myeloma (MM). Nonmyeloablative allogeneic transplantation might offer an option for cure without the high mortality associated with conventional conditioning. Here we present a retrospective analysis of patients with high-risk MM treated with nonmyeloablative allogeneic transplantation. In all, 52 patients with relapsed MM or high-risk features at diagnosis received 2 Gy TBI alone (n=3) or with fludarabine (n=49) as conditioning. Patients were heavily pretreated with a median of eight cycles of conventional chemotherapy and one or more autologous transplants for all but one patient. Regimen-related toxicity was low. Acute graft-versus-host disease II-IV occurred in 37% of patients, and 70% experienced chronic graft-versus-host disease (cGvHD). Median follow-up was 567 days, and transplant-related mortality was 17% in total. Estimated progression-free and overall survival at 18 months was 29.4 and 41.1%, respectively. Patients with cGvHD had a significantly higher progression-free survival, as did patients with up to eight cycles of pretreatment chemotherapy vs those with nine or more. In this highly pretreated patient group, disease control was unsatisfactory and our results suggest that a potential strategy might be to perform allogeneic transplant earlier in the course of the disease. 
650 4 |a Cell Biology 
650 4 |a general 
650 4 |a Hematology 
650 4 |a Internal Medicine 
650 4 |a Medicine/Public Health 
650 4 |a Public Health 
650 4 |a Stem Cells 
700 1 |a Görner, Martin  |d 1964-  |e VerfasserIn  |0 (DE-588)130475378  |0 (DE-627)707497817  |0 (DE-576)298218909  |4 aut 
700 1 |a Benner, Axel  |d 1959-  |e VerfasserIn  |0 (DE-588)106584686X  |0 (DE-627)81687221X  |0 (DE-576)425536602  |4 aut 
700 1 |a Hegenbart, Ute  |e VerfasserIn  |0 (DE-588)1028373708  |0 (DE-627)73062157X  |0 (DE-576)35901903X  |4 aut 
700 1 |a Klein, Ulrike  |d 1972-  |e VerfasserIn  |0 (DE-588)124868800  |0 (DE-627)36723338X  |0 (DE-576)294543015  |4 aut 
700 1 |a Schäfer, Hansjörg  |e VerfasserIn  |0 (DE-588)1251856160  |0 (DE-627)1789630339  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
773 0 8 |i Enthalten in  |t Bone marrow transplantation  |d London : Springer Nature, 1997  |g 36(2005), 11, Seite 963-969  |h Online-Ressource  |w (DE-627)320433366  |w (DE-600)2004030-1  |w (DE-576)091012996  |x 1476-5365  |7 nnas  |a Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma 
773 1 8 |g volume:36  |g year:2005  |g number:11  |g pages:963-969  |g extent:7  |a Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma 
856 4 0 |u https://doi.org/10.1038/sj.bmt.1705161  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/1705161  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220215 
993 |a Article 
994 |a 2005 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 8  |y j 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |d 50000  |e 910000PG102258023X  |e 910100PG102258023X  |e 50000PG102258023X  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 7 
998 |g 1251856160  |a Schäfer, Hansjörg  |m 1251856160:Schäfer, Hansjörg  |d 910000  |d 910100  |e 910000PS1251856160  |e 910100PS1251856160  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 124868800  |a Klein, Ulrike  |m 124868800:Klein, Ulrike  |d 910000  |d 910500  |e 910000PK124868800  |e 910500PK124868800  |k 0/910000/  |k 1/910000/910500/  |p 5 
998 |g 1028373708  |a Hegenbart, Ute  |m 1028373708:Hegenbart, Ute  |d 910000  |d 910100  |e 910000PH1028373708  |e 910100PH1028373708  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 106584686X  |a Benner, Axel  |m 106584686X:Benner, Axel  |p 3 
999 |a KXP-PPN1789625769  |e 4059970190 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","given":"Sabine","family":"Gerull","display":"Gerull, Sabine"},{"display":"Görner, Martin","family":"Görner","given":"Martin","role":"aut"},{"given":"Axel","role":"aut","family":"Benner","display":"Benner, Axel"},{"family":"Hegenbart","display":"Hegenbart, Ute","given":"Ute","role":"aut"},{"display":"Klein, Ulrike","family":"Klein","role":"aut","given":"Ulrike"},{"given":"Hansjörg","role":"aut","display":"Schäfer, Hansjörg","family":"Schäfer"},{"given":"Hartmut","role":"aut","family":"Goldschmidt","display":"Goldschmidt, Hartmut"},{"given":"Anthony Dick","role":"aut","family":"Ho","display":"Ho, Anthony Dick"}],"language":["eng"],"origin":[{"dateIssuedKey":"2005","dateIssuedDisp":"26 September 2005"}],"note":["Gesehen am 15.02.2022"],"title":[{"title":"Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma","title_sort":"Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"language":["eng"],"part":{"pages":"963-969","year":"2005","issue":"11","text":"36(2005), 11, Seite 963-969","extent":"7","volume":"36"},"note":["Gesehen am 17.01.25"],"origin":[{"publisherPlace":"London ; Basingstoke ; London","dateIssuedDisp":"1997-","publisher":"Springer Nature ; Macmillan ; Nature Publishing Group","dateIssuedKey":"1997"}],"pubHistory":["Nachgewiesen 19.1997 -"],"title":[{"title":"Bone marrow transplantation","title_sort":"Bone marrow transplantation"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myelomaBone marrow transplantation","recId":"320433366","physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1476-5365"],"zdb":["2004030-1"],"eki":["320433366"]}}],"recId":"1789625769","name":{"displayForm":["S. Gerull, M. Goerner, A. Benner, U. Hegenbart, U. Klein, H. Schaefer, H. Goldschmidt and A.D. Ho"]},"physDesc":[{"noteIll":"Diagramme","extent":"7 S."}],"id":{"doi":["10.1038/sj.bmt.1705161"],"eki":["1789625769"]}} 
SRT |a GERULLSABILONGTERMOU2620